From HCM to ATTR-CM: Rethinking Unexplained Hypertrophy
Hallie Blevins, PhD
Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
Erin Bohula, MD, DPhil
Lawrence Leiter
Closing Gaps in ASCVD Prevention: Lipid Management Insights from AHA 2025
Laurence Sperling, MD
Eugenia Gianos, MD
Managing Concomitant Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Evolving Care Strategies
Marlene Mimi Maeusli, PhD.
The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
Advancing Care for Women With Aortic Stenosis: 2-Year Outcomes for Women in the 5-Year SMART Trial
Roxana Mehran, MD, FSCAI
Highlights of the Latest Hypertension Guidelines
Clyde W. Yancy, MD
Clinical Perspective on New Therapies in Resistant Hypertension
Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health
Susan Davis
Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control
Navigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
Jun-ichi Abe
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40%
Scott Solomon, MD
The Fifth Pillar? Closing the Gap in HFrEF
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Javed Butler, MD
Stephen J. Greene, MD, FACC, FHFSA
Exploring Patient Perspectives on Genetic Testing for ATTR-CM
Shelina Ramnarine, PhD
Quan Bui, MD
Precision Medicine in Obstructive HCM Care: The Promise of Cardiac Myosin Inhibitors
Ahmad Masri, MD, MS
The Lp(a)-Lowering Landscape: Navigating Current and Future Therapeutic Options
Erin Michos
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.